NCT01866956

Brief Summary

The KSADS-COMP will facilitate identification of comorbid psychiatric and substance use diagnoses frequently missed in clinical practice, and improve adolescent treatment outcomes. The self-administered version of the KSADS-COMP can also be used cost-effectively in schools and juvenile justice settings where there is a growing interest in early identification and referral of youth in need of mental health services. The KSADS-Bridge assessment tool with its RDoC neurocognitive tasks, when completed with the self- or clinician administered KSADS-COMP, will help to create cross-talk between the DSM and RDoC diagnostic perspectives, and begin to generate a database on the relationship between RDoC constructs and treatment outcomes across a range of diagnostic categories.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
223

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2016

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 29, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 3, 2013

Completed
3.2 years until next milestone

Study Start

First participant enrolled

September 1, 2016

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2018

Completed
Last Updated

January 27, 2020

Status Verified

January 1, 2020

Enrollment Period

1.6 years

First QC Date

May 29, 2013

Last Update Submit

January 22, 2020

Conditions

Psychiatric Disorder

Outcome Measures

Primary Outcomes (1)

  • Wilcoxon rank sum tests.

    compare scores on disorder-specific symptom rating scales between those with and without a specific diagnoses

    within 2 days of criterion measure

Eligibility Criteria

Age11 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

adolescents aged 13-18 seeking psychiatric treatment at a rural mental health clinic

You may qualify if:

  • adolescent between the ages of 11 and 17

You may not qualify if:

  • Children will be excluded if they have a diagnosis of mental retardation (IQ \< 70) or a severe psychosis that would impair the child's ability to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hugo W. Moser Research Institute at Kennedy Krieger

Baltimore, Maryland, 21205, United States

Location

University of Pittsburgh

Pittsburgh, Pennsylvania, 15213, United States

Location

Related Publications (1)

  • Townsend L, Kobak K, Kearney C, Milham M, Andreotti C, Escalera J, Alexander L, Gill MK, Birmaher B, Sylvester R, Rice D, Deep A, Kaufman J. Development of Three Web-Based Computerized Versions of the Kiddie Schedule for Affective Disorders and Schizophrenia Child Psychiatric Diagnostic Interview: Preliminary Validity Data. J Am Acad Child Adolesc Psychiatry. 2020 Feb;59(2):309-325. doi: 10.1016/j.jaac.2019.05.009. Epub 2019 May 18.

    PMID: 31108163BACKGROUND

MeSH Terms

Conditions

Mental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Owner

Study Record Dates

First Submitted

May 29, 2013

First Posted

June 3, 2013

Study Start

September 1, 2016

Primary Completion

April 1, 2018

Study Completion

April 30, 2018

Last Updated

January 27, 2020

Record last verified: 2020-01

Locations

US(2)